[go: up one dir, main page]

AU2001287396A1 - Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature - Google Patents

Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature

Info

Publication number
AU2001287396A1
AU2001287396A1 AU2001287396A AU8739601A AU2001287396A1 AU 2001287396 A1 AU2001287396 A1 AU 2001287396A1 AU 2001287396 A AU2001287396 A AU 2001287396A AU 8739601 A AU8739601 A AU 8739601A AU 2001287396 A1 AU2001287396 A1 AU 2001287396A1
Authority
AU
Australia
Prior art keywords
nucleic acid
kits
selecting
methods
desired feature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001287396A
Inventor
Christian Lanctot
Pierre Moffat
Patrick Salois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phenogene Therapeutiques Inc
Original Assignee
Phenogene Therapeutiques Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phenogene Therapeutiques Inc filed Critical Phenogene Therapeutiques Inc
Publication of AU2001287396A1 publication Critical patent/AU2001287396A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001287396A 2000-08-18 2001-08-17 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature Abandoned AU2001287396A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/641,931 US6830885B1 (en) 2000-08-18 2000-08-18 Nucleic acid molecule, method and kit for selecting a nucleic acid having a desired feature
US09/641,931 2000-08-18
PCT/CA2001/001169 WO2002016572A2 (en) 2000-08-18 2001-08-17 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature

Publications (1)

Publication Number Publication Date
AU2001287396A1 true AU2001287396A1 (en) 2002-03-04

Family

ID=24574457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001287396A Abandoned AU2001287396A1 (en) 2000-08-18 2001-08-17 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature

Country Status (5)

Country Link
US (1) US6830885B1 (en)
EP (1) EP1322754A2 (en)
AU (1) AU2001287396A1 (en)
CA (1) CA2418097A1 (en)
WO (1) WO2002016572A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451957A1 (en) * 2001-06-28 2003-01-09 Phenogene Therapeutiques Inc. Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature
EP3404102B1 (en) 2004-04-21 2021-08-11 Alexion Pharmaceuticals, Inc. Bone delivery conjugates and method of using same to target proteins to bone
TWI438207B (en) * 2007-02-21 2014-05-21 Oncotherapy Science Inc Peptide vaccine for cancers exhibiting tumor-associated antigens
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
JP6055779B2 (en) 2010-12-27 2016-12-27 アレクシオン ファーマシューティカルズ， インコーポレイテッド Composition comprising natriuretic peptide and method of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
RU2708068C2 (en) 2014-12-05 2019-12-04 Алексион Фармасьютикалз, Инк. Treating convulsions using recombinant alkaline phosphatase
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
US11352612B2 (en) 2015-08-17 2022-06-07 Alexion Pharmaceuticals, Inc. Manufacturing of alkaline phosphatases
WO2017058822A1 (en) 2015-09-28 2017-04-06 Alexion Pharmaceuticals, Inc. Identifying effective dosage regimens for tissue non-specific alkaline phosphatase (tnsalp)-enzyme replacement therapy of hypophosphatasia
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
KR20220162816A (en) 2016-04-01 2022-12-08 알렉시온 파마슈티칼스, 인코포레이티드 Treating muscle weakness with alkaline phosphatases
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3464573A4 (en) 2016-06-06 2020-02-19 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
EP3500289B1 (en) 2016-08-18 2024-10-09 Alexion Pharmaceuticals, Inc. Asfotase alfa for use in treating tracheobronchomalacia
EP3600383A4 (en) 2017-03-31 2020-10-28 Alexion Pharmaceuticals, Inc. METHODS FOR TREATMENT OF HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
US20220003777A1 (en) * 2018-11-08 2022-01-06 The Board Of Trustees Of The Leland Stanford Junior University Methods Employing Mucin-Specific Proteases
WO2022173987A1 (en) 2021-02-12 2022-08-18 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217879A (en) * 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
JP2000505306A (en) 1996-02-26 2000-05-09 モルフォシス・アクチェンゲゼルシャフト Novel method for identifying nucleic acid sequences encoding two or more interacting (poly) peptides
US6197502B1 (en) 1997-11-17 2001-03-06 Cytos Biotechnology Ag Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property
WO1999036516A2 (en) 1998-01-16 1999-07-22 Biosource Technologies, Inc. Method of determining the function of nucleotide sequences and the proteins they encode by transfecting the same into a host
US6150098A (en) * 1998-02-20 2000-11-21 Amgen Inc. Methods for identifying novel secreted mammalian polypeptides

Also Published As

Publication number Publication date
EP1322754A2 (en) 2003-07-02
US6830885B1 (en) 2004-12-14
CA2418097A1 (en) 2002-02-28
WO2002016572A9 (en) 2003-02-13
WO2002016572A3 (en) 2003-05-01
WO2002016572A2 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
AU2001287396A1 (en) Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature
AU2001268513A1 (en) Nucleic acid accessible hybridization sites
AU2002217904A1 (en) Methods for efficiently minig broad data sets for biological markers
AU2002225888A1 (en) Double transposition methods for manipulating nucleic acids
AU2627201A (en) Methods and reagents for facilitating transcription
AUPQ968300A0 (en) Chemical methods
AU4028800A (en) Method for identifying accessible binding sites on rna
AU2001234455A1 (en) Informative nucleic acid arrays and methods for making same
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
AU2002367943A1 (en) Improved reagents and methods for producing parvoviruses
AU2001229576A1 (en) Nucleic acid binding site assay and selection method
AU2001290623A1 (en) Interbank process
AU2001293035A1 (en) Hydrocracking process
AU2001249170A1 (en) Method for modifying a nucleic acid
AU2002218440A1 (en) New process
AU2001294907A1 (en) Process for imparting corrosion resistance
AU2001268514A1 (en) Method for screening dna binding
AU2001252390A1 (en) Nucleic acid immunization
AU4764900A (en) Method for inserting a nucleic acid fragment in a vector, uses thereof and kits therefor
AU2001241853A1 (en) A method of reconstituting nucleic acid molecules
AU2001235282A1 (en) Circular extra-chromosomal dna elements
AU2001242507A1 (en) Method, diagnostic kit and microarray for determining the rhesus factor
AU5049001A (en) Dna analysis
AU2001271913A1 (en) Process guru
AU2001264117A1 (en) Chemical process